RE:Stock movesThe Oct. 31st meeting has come and gone. The vote to allow Andrew Schutte to own 22.3% of Replicel was ratified without fanfare.
Now that is in place it will be interesting to see if they are able to sell the remaining 5,500,000 shares with warrants after Andrew buys his 2,500,000. This PP closes as announced on nov. 18th.
This hopefully will give the company adequate funding to get the Dermal injector to the "finish line" and pay the legal bills to the conclusion of the Shiseido Arbitration.
This is all good but what the hell is really happening with this company. We get no updates on when the Dermal Injector will be submitted to the FDA for Approval and when will the Shiseido Arbitration conclude. Also what is happening in Japan with the often referenced partnership negotiations that have gone on endlessly for years ? Can I also add Yofoto the mystery company that owns 5,357,900 shares of the company (12.53% presently). What are they doing to fulfill the terms of their contract with Replicel ?
Possibly some sort of Update would be in order.